Testing for cystic fibrosis using allelic association.

AUTOR(ES)

Ivinson, A J

RESUMO

A particular haplotype defined by probes XV2c, KM19, and CS.7 at the D7S23 locus was found on 90% of chromosomes which carry cystic fibrosis (CF), but on only 11% of normal chromosomes in a UK sample of CF carriers. We show how such data can be used to calculate carrier risks for people with and without a family history of CF, and give examples of clinical applications. For parents or sibs of dead CF patients, phase and genotypes can often be assigned with only 1 to 2% error. However, this method is not suitable for prenatal testing where there is no history of CF; for couples with no family history, no fetus can be shown to be at more than 2% risk of being affected.

Documentos Relacionados

• Cystic Fibrosis Testing Comes of Age
• Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing
• Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group.
• Human immunodeficiency virus (HIV) antibody testing. Guidance from an opinion provided for the British Medical Association.
• Cystic fibrosis. 5. The current state of lung transplantation for cystic fibrosis.